clodronic acid has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aixinjueluo, W; Arai, S; Honda, A; Hosoi, M; Kataoka, K; Kobayashi, T; Kumano, K; Kurokawa, M; Miyauchi, M; Nakahata, T; Nakauchi, H; Niwa, A; Otsu, M; Taoka, K; Yamazaki, S; Yoshimi, A | 1 |
1 other study(ies) available for clodronic acid and Leukemia, Myelomonocytic, Chronic
Article | Year |
---|---|
Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate.
Topics: Aged; Animals; Cell Differentiation; Clodronic Acid; Disease Models, Animal; Drug Repositioning; Enhancer of Zeste Homolog 2 Protein; Hematopoietic Stem Cells; Humans; Induced Pluripotent Stem Cells; Leukemia, Myelomonocytic, Chronic; Liposomes; Male; Mice; Neurofibromin 1; Phosphorylation; Protein Kinase Inhibitors; STAT5 Transcription Factor; Teratoma; Transplantation, Heterologous | 2018 |